BECLOMETASONE/FORMOTEROL/GLYCOPYRRONIUM VS. FIXED AND OPEN COMBINATIONS OF INHALED CORTICOSTEROIDS, LONG-ACTING B2-AGONIST, AND LONG-ACTING MUSCARINIC ANTAGONIST IN ADULTS WITH UNCONTROLLED ASTHMA: A NETWORK META-ANALYSIS

被引：0
|
作者：
Orlovic, M. [1 ]
Nikolaidis, G. [2 ]
Tzelis, D. [3 ]
Barouma, I [3 ]
Vele, A. [1 ]
Kots, M. [1 ]
van der Deijl, M. [1 ]
Madoni, A. [4 ]
机构：
[1] Chiesi Farmaceutici Spa, Parma, PR, Italy
[2] IQVIA, London, England
[3] IQVIA Ltd, Athens, Attica, Greece
[4] Chiesi Farmaceutici Spa, Parma, PR, Italy
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE556
引用
收藏
页码：S159 / S160
页数：2
相关论文
共 50 条
  • [41] Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent Asthma
    Krishnan, Jerry A.
    Lazarus, Stephen C.
    Blake, Kathryn, V
    Sorkness, Christine A.
    Covar, Ronina
    Dyer, Anne-Marie
    Lang, Jason E.
    Lugogo, Njira L.
    Mauger, David T.
    Wechsler, Michael E.
    Wenzel, Sally E.
    Cardet, Juan Carlos
    Castro, Mario
    Israel, Elliot
    Phipatanakul, Wanda
    King, Tonya S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (03) : 372 - 380
  • [42] Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis
    Lee, Hyun Woo
    Kim, Hyung Jun
    Jang, Eun Jin
    Lee, Chang-Hoon
    RESPIRATION, 2021, 100 (07) : 631 - 643
  • [43] Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis (vol 319, pg 1473, 2018)
    Sobieraj, D. M.
    Baker, W. L.
    Nguyen, E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (18): : 1939 - 1939
  • [44] Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis
    Oba, Yuji
    Lone, Nazir A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 469 - 479
  • [45] Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis
    Ismaila, Afisi Segun
    Huisman, Eline L.
    Punekar, Yogesh Suresh
    Karabis, Ndreas
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2495 - 2517
  • [46] LONG-ACTING ANTICHOLINERGIC AGENTS IN PATIENTS WITH UNCONTROLLED ASTHMA: A SYSTEMATIC REVIEW & META-ANALYSIS
    Kim, Y. H.
    Lee, S. W.
    RESPIROLOGY, 2014, 19 : 68 - 68
  • [47] Long-acting anticholinergic agents in patients with uncontrolled asthma: a systematic review and meta-analysis
    Lee, S. W.
    Kim, H. J.
    Yoo, K. H.
    Park, Y. B.
    Park, J-Y.
    Jung, J. Y.
    Moon, J-Y.
    Byun, M. K.
    Kim, S. W.
    Kim, Y. H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (12) : 1421 - 1430
  • [48] PROPHYLAXIS OF EXERCISE-INDUCED ASTHMA WITH INHALED FORMOTEROL, A LONG-ACTING BETA-2-ADRENERGIC AGONIST
    MCALPINE, LG
    THOMSON, NC
    RESPIRATORY MEDICINE, 1990, 84 (04) : 293 - 295
  • [49] An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
    Alakeel, Yousif S.
    Khader, Esraa
    Altuwayli, Norah
    Alrammah, Shahad
    Abdel-Razaq, Wesam
    SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (03) : 300 - 305
  • [50] Projections of Healthcare Resource Utilization and Costs Related to Exacerbations for Budesonide/Glycopyrrolate/Formoterol Fumarate Versus Dual Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist and Inhaled Corticosteroid/Long-Acting β2-Agonist Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease
    De Nigris, E.
    Treharne, C.
    Brighton, N.
    Holmgren, U.
    Walker, A.
    Haughney, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345